Erlotinib (100mg)
Erlocip 100 Tablet is prescribed for the treatment of pancreatic cancer and non-small cell lung cancer. Specifically, it is employed to treat malignancies that have metastasized to other regions of the body or are locally advanced.
Erlocip 100 Tablet is a targeted therapy that is used to treat pancreatic cancer and non-small cell lung cancer. It functions by impeding the proliferation and dissemination of cancer cells by inhibiting EGFR, a receptor. The medication is administered on an empty stomach and necessitates meticulous monitoring due to potential adverse effects, such as acute diarrhea, altered liver function, and increased sensitivity to sunlight.
It is crucial to maintain hydration and consult with your physician if symptoms persist, as severe diarrhea may occur in uncommon instances. While taking this medication, your physician may suggest that you undergo routine liver function testing.
strip of 30 tablets
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Erlocip 100 Tablet should be consumed on an empty stomach. Consume it either one hour prior to or two hours following a meal. The duration and dosage of treatment are contingent upon your medical condition and response to treatment. Do not discontinue the medication unless your physician has instructed you to do so, even if you do not observe any immediate benefits.
Erlocip 100 Tablet is an anti-cancer medication that inhibits the activity of epidermal growth factor receptors (EGFR) on cancer cells. Erlocip 100 Tablet impedes or halts the progression of the disease by disrupting the signaling pathways that promote the growth and spread of cancer cells by binding to EGFR.
Related Warnings
The impact of alcohol on Erlocip 100 Tablet is not well understood. It is recommended that you consult with your physician prior to imbibing alcohol while taking this medication.
The use of Erlocip 100 Tablet during pregnancy is not recommended due to the substantial risk it presents to the developing infant. Please seek the advice of your physician and explore alternative treatments if you are expectant or intending to become pregnant.
It is probable that Erlocip 100 Tablet is hazardous for use while lactating. The drug has the potential to enter breast milk and cause damage to the infant. Before breastfeeding while taking this medication, it is important to consult with your physician.
The impact of Erlocip 100 Tablet on your driving capabilities is uncertain. Avoid driving or operating heavy machinery until you are able to do so safely if you are experiencing symptoms such as vertigo, fatigue, or vision changes.
Erlocip 100 Tablet is generally safe for use in patients with kidney disease, and no dose adjustment is typically necessary. Nevertheless, it is not advised for patients with severe kidney disease to utilize it.
Erlocip 100 Tablet should be administered with caution to patients who have liver disease. It is crucial to consult with your physician if you have any hepatic conditions, as a dose adjustment may be required.
Q: What is the recommended method of administration for Erlocip 100 Tablet?
A: It is recommended that the Erlocip 100 Tablet be consumed on an empty stomach, either one hour prior to or two hours following all meals. To ensure consistency, it is crucial to consume it at the same time each day.
Q: Is Erlocip 100 Tablet classified as a chemotherapy medication?
A: Erlocip 100 Tablet is not classified as a conventional chemotherapy medication. It is a member of the kinase inhibitor class of medications and functions by inhibiting the activity of a protein that stimulates the proliferation of cancer cells.
Q: What is the recommended duration of use for Erlocip 100 Tablet?
A: The duration of treatment is contingent upon the unique requirements of each patient. Erlocip 100 Tablet should be administered for the duration specified by your physician.
Q: Is it possible for smoking to impact the efficacy of Erlocip 100 Tablet?
A: Indeed, the efficacy of Erlocip 100 Tablet can be substantially diminished by smoking. It is advisable to discontinue smoking prior to commencing treatment.
Q: What should I do if I develop a rash while consuming Erlocip 100 Tablet?
A: Rash is a prevalent adverse consequence. Consult your physician for guidance on how to manage it, and exercise caution when exposed to the sun.
Q: What is the earliest possible time to begin planning for pregnancy after discontinuing Erlocip 100 Tablet?
A: After discontinuing Erlocip 100 Tablet, refrain from becoming pregnant for a minimum of one month. Please seek additional advice from your physician.
Q: Does Erlocip 100 Tablet affect vision?
A: Vision alterations may result from the use of Erlocip 100 Tablet. Consult your physician immediately if you perceive any deterioration in your vision or eye pain.
